StockData
ELI LILLY & Co logo

ELI LILLY & Co (LLY) operating KPIs

LLYNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 20/3026% above fair value
$1417.54+43.84 (+3.19%)

Close on Oct 30, 2026Market cap $1.33TP/E 46.0Yield 0.44%

Eli Lilly operating lease weighted-average discount rate (%) (%)

Form 10-K Leases Note

Latest, FY2025
4.7%
Period ended Dec 31, 2025
Change on a year earlier
+0.1 pts
4.6% in FY2024
History
7 years
Since FY2019
Sources
6
Documents cited below

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedOperating lease weighted-average discount rate (%) (%)Year on yearSource
FY2025Dec 31, 20254.7%+0.1 ptsForm 10-K (filed 2026-02-12) ↗
FY2024Dec 31, 20244.6%+0.2 ptsForm 10-K (filed 2026-02-12) ↗
FY2023Dec 31, 20234.4%+0.8 ptsForm 10-K (filed 2025-02-19) ↗
FY2022Dec 31, 20223.6%+0.6 ptsForm 10-K (filed 2024-02-21) ↗
FY2021Dec 31, 20213.0%-0.3 ptsForm 10-K (filed 2023-02-22) ↗
FY2020Dec 31, 20203.3%-0.3 ptsForm 10-K (filed 2022-02-23) ↗
FY2019Dec 31, 20193.6%–Form 10-K (filed 2021-02-17) ↗

Cite this data

StockData. (2026). Eli Lilly Operating lease weighted-average discount rate (%) (%), annual FY2019–FY2025 [Data set]. Compiled from Eli Lilly SEC filings and investor materials. https://stockdatahq.com/stocks/lly/kpis/op_lease_disc_rate

See every metric in the Eli Lilly KPI table. Data updated Oct 25, 2026.